HCMT
BMY icon

Highland Capital Management (Tennessee)’s Bristol-Myers Squibb BMY Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,672
Closed -$1.98M – 419
2026
Q1 		$1.98M Buy
+32,672
New +$1.9M 0.1% 169
2024
Q3 		– Sell
-66,145
Closed -$2.75M – 377
2024
Q2 		$2.75M Sell
66,145
-5,544
-8% -$248K 0.16% 146
2024
Q1 		$3.89M Sell
71,689
-742
-1% -$37.8K 0.22% 124
2023
Q4 		$3.72M Buy
72,431
+225
+0.3% +$11.8K 0.23% 130
2023
Q3 		$4.19M Sell
72,206
-5,625
-7% -$345K 0.29% 101
2023
Q2 		$4.98M Sell
77,831
-1,155
-1% -$77.5K 0.32% 96
2023
Q1 		$5.47M Sell
78,986
-520
-0.7% -$36.7K 0.41% 69
2022
Q4 		$5.72M Sell
79,506
-400
-0.5% -$30.2K 0.4% 63
2022
Q3 		$5.68M Sell
79,906
-3,650
-4% -$265K 0.44% 57
2022
Q2 		$6.43M Buy
83,556
+3,120
+4% +$238K 0.46% 50
2022
Q1 		$5.87M Buy
80,436
+1,810
+2% +$122K 0.35% 77
2021
Q4 		$4.9M Sell
78,626
-1,100
-1% -$64.5K 0.28% 104
2021
Q3 		$4.72M Sell
79,726
-3,110
-4% -$205K 0.29% 102
2021
Q2 		$5.54M Sell
82,836
-42,480
-34% -$2.77M 0.33% 81
2021
Q1 		$7.91M Buy
125,316
+31,844
+34% +$1.98M 0.49% 59
2020
Q4 		$5.8M Sell
93,472
-36,099
-28% -$2.22M 0.37% 73
2020
Q3 		$7.81M Sell
129,571
-1,636
-1% -$98.5K 0.56% 49
2020
Q2 		$7.71M Buy
131,207
+9,825
+8% +$588K 0.6% 44
2020
Q1 		$6.77M Sell
121,382
-17,824
-13% -$1.09M 0.64% 42
2019
Q4 		$8.94M Buy
139,206
+34,624
+33% +$1.98M 0.62% 47
2019
Q3 		$5.3M Buy
+104,582
New +$4.92M 0.39% 76
2018
Q4 		– Sell
-22,964
Closed -$1.43M – 310
2018
Q3 		$1.43M Buy
22,964
+11,042
+93% +$655K 0.1% 188
2018
Q2 		$660K Sell
11,922
-150
-1% -$8.1K 0.05% 255
2018
Q1 		$764K Buy
12,072
+1,610
+15% +$104K 0.06% 239
2017
Q4 		$641K Buy
10,462
+366
+4% +$22.9K 0.05% 244
2017
Q3 		$644K Buy
10,096
+2,267
+29% +$132K 0.05% 239
2017
Q2 		$436K Sell
7,829
-11,027
-58% -$600K 0.04% 284
2017
Q1 		$1.02M Sell
18,856
-3,650
-16% -$200K 0.08% 189
2016
Q4 		$1.32M Sell
22,506
-6,560
-23% -$359K 0.11% 176
2016
Q3 		$1.57M Buy
29,066
+21,356
+277% +$1.37M 0.13% 168
2016
Q2 		$567K Sell
7,710
-10
-0.1% -$707 0.05% 252
2016
Q1 		$493K Buy
+7,720
New +$487K 0.04% 258
2015
Q4 		– Sell
-750
Closed -$44K – 335
2015
Q3 		$44K Hold
750
– – ﹤0.01% 387
2015
Q2 		$50K Buy
+750
New +$49.4K ﹤0.01% 384

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Highland Capital Management (Tennessee)'s BMY Position: Q2 2026 in Review

Highland Capital Management (Tennessee) sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 32,672 shares — an estimated $1.98M sold.

Highland Capital Management (Tennessee) first reported a position in BMY in Q2 2015 and held it in 34 quarters. The position peaked at $8.94M in Q4 2019. 1,246 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Highland Capital Management (Tennessee) reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 32,672 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.98M.
  • Highland Capital Management (Tennessee) first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 34 quarters.
  • Highland Capital Management (Tennessee)'s Bristol-Myers Squibb position peaked at $8.94M in Q4 2019.
  • 1,246 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.